however, for patients beginning semaglutide treatment, functional medicine specialists often suggest aiming for 40-60 ng/mL for optimal metabolic support
The Bridge covers three medications: Wegovy (semaglutide injectable), Foundayo (orforglipron, the oral once-daily pill from Eli Lilly), and Zepbound KwikPen (tirzepatide in a multi-dose pen device)
and serves on a speaker's bureau for AstraZeneca, Novo Nordisk, Eli Lilly, Sanofi, Merck Sharp & Dohme, Boehringer Ingelheim and Janssen
In particular, Frssing et al
Effect of Clostridium butyricum on gastrointestinal infections